Dr. Meagan Jacoby, M.D., Ph.D.
Claim this profileWashington University School of Medicine
About Meagan Jacoby, M.D., Ph.D.
Education:
- MD from Washington University School of Medicine.
- PhD in Molecular Genetics and Genomics from Washington University School of Medicine.
Experience:
- Specializes in leukemia at the Siteman Cancer Center.
- Contributes to research, diagnosis, and treatment in her field.
Area of expertise
Myelodysplastic Syndrome
Meagan Jacoby, M.D., Ph.D. has run 9 trials for Myelodysplastic Syndrome.
Acute Myeloid Leukemia
Meagan Jacoby, M.D., Ph.D. has run 8 trials for Acute Myeloid Leukemia. Some of their research focus areas include:
Affiliated Hospitals
Washington University School Of Medicine
Washington University
Clinical Trials Meagan Jacoby, M.D., Ph.D. is currently running
ChromoSeq
for Myelodysplastic Syndrome
This is a single institution, prospective study of the whole genome sequencing assay, ChromoSeq. Using prospectively collected patient data, coupled with physician surveys, the investigators seek to determine the feasibility of implementing ChromoSeq in addition to standard genomic testing, for patients with the diagnosis of myelodysplastic syndrome (MDS).
Recruiting
1 award
N/A
8 criteria
Statins
for Myelodysplastic Syndrome
This trial is testing if statins, drugs usually used to lower cholesterol, can help patients with certain blood disorders by reducing inflammation and slowing disease progression. These patients currently have no effective treatments and are at risk of their condition worsening. Statins are commonly prescribed medications that have multiple beneficial effects.
Recruiting
1 award
Phase 2
More about Meagan Jacoby, M.D., Ph.D.
Clinical Trial Related
3 years of experience running clinical trials · Led 21 trials as a Principal Investigator · 6 Active Clinical Trials
Treatments Meagan Jacoby, M.D., Ph.D. has experience with
- ChromoSeq
- Cytokine Induced Memory-like NK Cell Adoptive Therapy
- Fludarabine
- Pacritinib
- DEC-C
- MyeloSeq-HD
Breakdown of trials Meagan Jacoby, M.D., Ph.D. has run
Myelodysplastic Syndrome
Acute Myeloid Leukemia
Graft-versus-Host Disease
GVHD
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Meagan Jacoby, M.D., Ph.D. specialize in?
Meagan Jacoby, M.D., Ph.D. focuses on Myelodysplastic Syndrome and Acute Myeloid Leukemia. In particular, much of their work with Myelodysplastic Syndrome has involved treating patients, or patients who are undergoing treatment.
Is Meagan Jacoby, M.D., Ph.D. currently recruiting for clinical trials?
Yes, Meagan Jacoby, M.D., Ph.D. is currently recruiting for 6 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Meagan Jacoby, M.D., Ph.D. has studied deeply?
Yes, Meagan Jacoby, M.D., Ph.D. has studied treatments such as ChromoSeq, Cytokine Induced Memory-like NK Cell Adoptive Therapy, Fludarabine.
What is the best way to schedule an appointment with Meagan Jacoby, M.D., Ph.D.?
Apply for one of the trials that Meagan Jacoby, M.D., Ph.D. is conducting.
What is the office address of Meagan Jacoby, M.D., Ph.D.?
The office of Meagan Jacoby, M.D., Ph.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.